Erythromycin Tablets

Antibiotics · Tablets / Suspension · 250mg / 500mg

Trade Information

Minimum Order Qty	1,000,000 tablets
Capacity	100 Million Tablets per month
Strength	250mg / 500mg
Private Labelling	Custom branding, artwork & market-specific labelling
Lead Time	45–60 days from order confirmation
Payment Terms	LC at sight, TT (advance / against documents)
Shipping	FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia	BP, USP, IP compliant

Packing Options

Blister (Alu-Alu / Alu-PVC)
Strip pack
Bottle pack (HDPE)
Hospital bulk pack
Custom packing as per buyer requirement

Regulatory & Quality

Registration Status	Registered in multiple African, Asian, and CIS markets. Dossier available for new market registration.
Regulatory Dossiers	CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data	Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification	WHO-GMP Certified

Product Details

Composition	Erythromycin (as Stearate / Ethylsuccinate)
Dosage Form	Tablets / Suspension
Pack Size	10x10, Bottle of 100/500 / Custom packing available
Storage	Store below 30°C in a dry place, protected from light and moisture
Shelf Life	24 months from date of manufacture

Description

Erythromycin is the original macrolide antibiotic and a long-established treatment option, valued particularly as an alternative for patients with penicillin allergy. It is listed on the WHO Model List of Essential Medicines.

BioGalen manufactures Erythromycin in tablet and paediatric suspension forms. Its enduring procurement value is as a non-penicillin macrolide option for common respiratory and skin infections, a dependable, low-cost component of antibiotic formularies.

Mechanism of Action

Erythromycin is the original macrolide antibiotic. It inhibits bacterial protein synthesis by binding reversibly to the 50S ribosomal subunit and blocking translocation of the growing peptide chain. This bacteriostatic action covers many Gram-positive organisms and atypical pathogens. Because its mechanism is unrelated to the beta-lactams, Erythromycin is a valuable alternative for patients who cannot take penicillins.

Indications

Respiratory tract infections
Skin and soft tissue infections
Penicillin-allergy alternative for susceptible infections
Certain sexually transmitted and atypical infections (as directed)

Available Variants

Erythromycin Tablets 250mg
Erythromycin Tablets 500mg
Erythromycin Oral Suspension

Frequently Asked Questions

How does Erythromycin differ from Azithromycin?

Erythromycin is the original macrolide with a long track record and shorter dosing intervals, while Azithromycin is a newer macrolide with a longer half-life allowing shorter, once-daily courses. Both are used for respiratory and skin infections and as penicillin alternatives.

Why is Erythromycin still used?

Erythromycin remains a dependable, low-cost macrolide on essential medicines lists, valued particularly as an alternative for penicillin-allergic patients and for respiratory and skin and soft tissue infections.

What forms of Erythromycin does BioGalen manufacture?

BioGalen manufactures Erythromycin as tablets and a paediatric suspension, under WHO-GMP with CTD and ACTD dossiers available.

Explore More

Interested in Erythromycin Tablets?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.

WhatsApp Enquiry Contact Us

Browse Categories

Browse by Dosage Form